Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (3858)	2/21/1998 5:21:00 PM
From: JOHN W.	Respond to of 6136

Subj: Pfizer By: biotime1 Date: Feb 21 1998 2:19 P.M PST Reply To: Msg. 221 by biotime1 The recent surge in this stock was not Chicago and scrip numbers. It was continued speculation of the takeover rumors and talks between Pfizer and Agouron which is forcing the precarious positioon of short interset to cont to roll the disproportionately large options activity. this stock ha s been a favorite in stock manipulation and now the cycle of up price manipulation by MM is just beggining. A new high should be reached in a matter of 3-5 weeks. i would guess, prior to the official announcement we should see 59 with 60 the major barrier.